CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In order to further elucidate the significance of the HH pathway in CML, RNA sequencing analysis was performed on CD34+ stem/progenitor cells obtained at diagnosis from six CP-CML patients and three healthy bone marrow (HBM) controls [60,61].